Wellington Management Group LLP increased its holdings of GENFLEET-B (02595) by 2.5242 million shares, with an approximate price per share of around 27.26 Hong Kong dollars.

19:53 19/03/2026

On March 17, Wellington Management Group LLP increased its holdings in Jianfeng Pharmaceutical-B (02595) by 2.5242 million shares, with a price of HKD 27.259 per share, for a total amount of approximately HKD 68.8072 million.

According to the latest data from the Hong Kong Stock Exchange, on March 17th, Wellington Management Group LLP increased its holdings of GENFLEET-B (02595) by 2.5242 million shares, with a price of 27.259 Hong Kong dollars per share. The total amount is approximately 68.8072 million Hong Kong dollars. After the increase, the new number of shares held is approximately 17.7694 million, with a stake of 5.26%.

CHINA HONGBAO(08316): Liu Huiqing appointed as independent non-executive director.

CHINARES PHARMA(03320): Dong-E-E-Jiao's net profit attributable to shareholders in 2025 is estimated to be approximately 1.739 billion yuan, an increase of 11.66% year-on-year.

Hong Kong-listed AI medical stock buys back the first share! YIDU TECH (02158) repurchased nearly 15 million Hong Kong dollars on March 19, deepening regional layout with Guangxi Medical University.

CHINA HONGBAO(08316): Liu Huiqing appointed as independent non-executive director.

CHINARES PHARMA(03320): Dong-E-E-Jiao's net profit attributable to shareholders in 2025 is estimated to be approximately 1.739 billion yuan, an increase of 11.66% year-on-year.

Hong Kong-listed AI medical stock buys back the first share! YIDU TECH (02158) repurchased nearly 15 million Hong Kong dollars on March 19, deepening regional layout with Guangxi Medical University.